← Open Payments lookup

JILLIAN DICKENSKI: Open Payments

NPI 1700580438 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,161 in 61 payments from 20 companies in 2025. Trend: 2023 $31 · 2024 $890 · 2025 $1,161

Food & beverage: $1,161
CompanyPaymentsAmount
PFIZER INC.9$174
Novo Nordisk Inc7$139
Bayer Healthcare Pharmaceuticals Inc.6$123
AstraZeneca Pharmaceuticals LP5$89
Boehringer Ingelheim Pharmaceuticals, Inc.4$76
ABBVIE INC.4$76
Teva Pharmaceuticals USA, Inc.4$69
Lilly USA, LLC3$56
Axsome Therapeutics, Inc.3$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54

Products named: Kerendia, JARDIANCE, NURTEC ODT, VYNDAQEL, AUSTEDO XR, Auvelity, CAPLYTA, FARXIGA.

Industry payments across MD — which companies pay providers there.